John Celebi
Amministratore Delegato presso SENSEI BIOTHERAPEUTICS, INC.
Patrimonio netto: 62 495 $ in data 30/04/2024
Posizioni attive di John Celebi
Società | Posizione | Inizio | Fine |
---|---|---|---|
SENSEI BIOTHERAPEUTICS, INC. | Direttore/Membro del Consiglio | 01/02/2018 | - |
Amministratore Delegato | 01/02/2018 | - | |
Presidente | 01/02/2018 | - | |
Panacea Pharmaceuticals, Inc.
Panacea Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Panacea Pharmaceuticals, Inc. develops precision cancer therapeutic products. The company was founded by Hossein A. Ghanbari and Kasra Ghanbari in 1999 and is headquartered in Gaithersburg, MD. | Direttore/Membro del Consiglio | - | - |
Amministratore Delegato | - | - | |
Presidente | - | - | |
Egle Therapeutics SAS
Egle Therapeutics SAS Miscellaneous Commercial ServicesCommercial Services Egle Therapeutics SAS is a biotech company based in Paris, France. Egle Therapeutics develops first-in-class immunotherapies targeting immune suppressor regulatory T cells (Tregs) for oncology and autoimmune diseases. The French company leverages its translational-based target discovery platform to unveil novel therapeutic Treg targets and computationally designed immunocytokines acting as antagonists or as selective Treg-agonists. The company was founded in 2020 by Luc Boblet, a serial biotech entrepreneur, and Dr. Eliane Piaggio, a renowned immunologist. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di John Celebi
Precedenti posizioni note di John Celebi
Società | Posizione | Inizio | Fine |
---|---|---|---|
X4 Pharmaceuticals, Inc. /Old/
X4 Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology X4 Pharmaceuticals, Inc. develops novel therapeutics designed to improve immune cell trafficking to treat cancer and rare diseases. It offers X4P-001-RD, X4P-001-IO, and X4P-002. The company was founded by Paula Ragan, Alan Walts, Michael Gilman, Henri Termeer, Keith Flaherty, Renato Skerlj, and Richard Peters in July 2014 and is headquartered in Cambridge, MA. | Direttore operativo | 01/06/2016 | 01/02/2018 |
Igenica Biotherapeutics, Inc.
Igenica Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Igenica Biotherapeutics, Inc. develops therapeutics for the treatment of cancer. It develops antibodies and antibody-drug conjugates (ADCs) for the treatment of cancer. The firm offers recombinant monoclonal antibodies for oncology and cancer treatment. The company was founded by Robert Schreiber and Guoqing Chen in 2008 and is headquartered in Burlingame, CA. | Corporate Officer/Principal | 25/08/2011 | 01/01/2016 |
ARQULE, INC. | Corporate Officer/Principal | 01/01/2003 | 01/01/2011 |
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - | - |
Cyclis Pharmaceuticals, Inc.
Cyclis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cyclis Pharmaceuticals, Inc. researches and develops small molecule drugs for the treatment of cancer. It is engaged in the discovery and development of novel drugs which are based on the restoration and activation of cellular checkpoints. The company is headquartered in Norwood, MA. | Corporate Officer/Principal | - | - |
AGILENT TECHNOLOGIES, INC. | Corporate Officer/Principal | - | - |
░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
Formazione di John Celebi
Carnegie Mellon University | Masters Business Admin |
University of California San Diego | Undergraduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 12 |
Francia | 2 |
Posizioni
Corporate Officer/Principal | 6 |
Director/Board Member | 3 |
Chief Executive Officer | 2 |
Settori
Health Technology | 9 |
Consumer Services | 3 |
Commercial Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 2 |
---|---|
AGILENT TECHNOLOGIES, INC. | Health Technology |
SENSEI BIOTHERAPEUTICS, INC. | Health Technology |
Aziende private | 8 |
---|---|
Igenica Biotherapeutics, Inc.
Igenica Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Igenica Biotherapeutics, Inc. develops therapeutics for the treatment of cancer. It develops antibodies and antibody-drug conjugates (ADCs) for the treatment of cancer. The firm offers recombinant monoclonal antibodies for oncology and cancer treatment. The company was founded by Robert Schreiber and Guoqing Chen in 2008 and is headquartered in Burlingame, CA. | Health Technology |
ArQule, Inc.
ArQule, Inc. Pharmaceuticals: MajorHealth Technology ArQule, Inc. is a biopharmaceutical company, which engages in the research and development of therapeutics to treat cancers and rare diseases. The company was founded in 1993 and is headquartered in Burlington, MA. | Health Technology |
Tularik, Inc.
Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | Commercial Services |
Cyclis Pharmaceuticals, Inc.
Cyclis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cyclis Pharmaceuticals, Inc. researches and develops small molecule drugs for the treatment of cancer. It is engaged in the discovery and development of novel drugs which are based on the restoration and activation of cellular checkpoints. The company is headquartered in Norwood, MA. | Health Technology |
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | Health Technology |
X4 Pharmaceuticals, Inc. /Old/
X4 Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology X4 Pharmaceuticals, Inc. develops novel therapeutics designed to improve immune cell trafficking to treat cancer and rare diseases. It offers X4P-001-RD, X4P-001-IO, and X4P-002. The company was founded by Paula Ragan, Alan Walts, Michael Gilman, Henri Termeer, Keith Flaherty, Renato Skerlj, and Richard Peters in July 2014 and is headquartered in Cambridge, MA. | Health Technology |
Panacea Pharmaceuticals, Inc.
Panacea Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Panacea Pharmaceuticals, Inc. develops precision cancer therapeutic products. The company was founded by Hossein A. Ghanbari and Kasra Ghanbari in 1999 and is headquartered in Gaithersburg, MD. | Health Technology |
Egle Therapeutics SAS
Egle Therapeutics SAS Miscellaneous Commercial ServicesCommercial Services Egle Therapeutics SAS is a biotech company based in Paris, France. Egle Therapeutics develops first-in-class immunotherapies targeting immune suppressor regulatory T cells (Tregs) for oncology and autoimmune diseases. The French company leverages its translational-based target discovery platform to unveil novel therapeutic Treg targets and computationally designed immunocytokines acting as antagonists or as selective Treg-agonists. The company was founded in 2020 by Luc Boblet, a serial biotech entrepreneur, and Dr. Eliane Piaggio, a renowned immunologist. | Commercial Services |
- Borsa valori
- Insiders
- John Celebi
- Esperienza